Brian H. Craig

Delta Delta 1998

Election Date: 2024

Brian Craig has spent his career developing innovative products to advance medical care for patients around the world.

Leading Innovation in the Medical Device Industry
Brian started his professional career at Medtronic where he helped establish cardiac resynchronization therapy (CRT), which is a multi-billion-dollar market and standard-of care therapy to treat heart failure. Brian also focused on early-stage innovation, including the leadless pacing program leading to the Micra™ pacemaker, the world’s smallest pacemaker. He also started the extravascular implantable cardioverter-defibrillator program, which recently received FDA approval.

In 2009, Brian left Medtronic to join ev3, a small business that developed peripheral vascular and neurovascular innovations. At ev3 he led the atherectomy franchise and turned it into the fastest growing franchise in the business. This success led to the acquisition of ev3 by Covidien.  As a part of Covidien, Brian served as VP Marketing-Emerging Markets and moved to Singapore where he had marketing responsibility across all geographies except the US and Europe. His primary responsibility was establishing an R&D center in Shanghai with over 200 engineers to build products to accelerate growth in emerging markets. During this time, Covidien was the fastest growing, large medical device company throughout emerging markets.

For more of Brian’s story go to Significant Sig Brian Craig.